Revenue Guidance
-
Financial
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., August 2, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., May 5, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
March 2, 2023 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Financial
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
November 10, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Financial
OrthoPediatrics Corp. Reports Third Quarter 2022 Financial Results and Updates 2022 Revenue Guidance
Third Quarter 2022 Record Revenue Increased 39% Year-over-Year WARSAW, Ind., November 1, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”)…
Read More » -
Financial
SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance
CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
ATEC Announces Select Preliminary Third Quarter 2022 Financial Results and Raises Guidance
\ Total revenue of $89 to $90 million Total revenue growth of 42% to 43%, including organic revenue growth of…
Read More » -
Financial
Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Top Stories
ATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance
Total revenue grows 35% to $84 million, including organic revenue growth of 30%EOS imaging generates revenue of $12 millionCompany increases…
Read More » -
Financial
Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Financial
Paragon 28 Reports First Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
May 9, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Financial
ATEC Reports First Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance
Revenue growth of 61%, including organic revenue growth of 39%EOS imaging revenue of over $10 millionFull-year revenue guidance increased to…
Read More » -
Financial
SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results
Provides 2022 Revenue Guidance CARLSBAD, Calif., March 11, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical…
Read More » -
Financial
Paragon 28 Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Net Revenue Guidance
March 8, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports Third Quarter 2021 Financial Results and Provides 2021 Fourth Quarter Net Revenue Guidance
November 22, 2021 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More »